New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands

The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms

(2017) Gisela Kobelt et al.   Multiple Sclerosis Journal

New insights into the burden and costs of multiple sclerosis in Europe

(2017) Gisela Kobelt et al.   Multiple Sclerosis Journal

The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms

(2017) Gisela Kobelt et al.   Multiple Sclerosis Journal

New insights into the burden and costs of multiple sclerosis in Europe

(2017) Gisela Kobelt et al.   Multiple Sclerosis Journal

A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study

(2016) Helga Westerlind et al.   Multiple Sclerosis Journal

From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare

(2016) Matthijs Versteegh et al.   PHARMACOECONOMICS

A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study

(2016) Helga Westerlind et al.   Multiple Sclerosis Journal

Brain health: time matters in multiple sclerosis

(2016) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996–2008

(2012) M.A. Kramer et al.   NEUROEPIDEMIOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Do Productivity Costs Matter?

(2011) Marieke Krol et al.   PHARMACOECONOMICS

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients

(2009) M Debouverie et al.   Multiple Sclerosis Journal

Will Rogers phenomenon in multiple sclerosis

(2008) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY